Entecavir soft capsule and its preparation method

A technology of entecavir and soft capsules, which is applied in the field of entecavir soft capsules for the treatment of hepatitis B and its preparation, and can solve the problems that many pharmaceutical factories, government departments, scientific research institutes and other institutions are conducting research work on the drug

Inactive Publication Date: 2006-02-15
FUKANGREN BIO PHARMA
View PDF0 Cites 10 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

At present, there is no dosage form of Entecavir on the market in the domestic market, but many pharmaceutical companies, government departments, scientific research institutes and other institutions are conducting research on this drug

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Entecavir soft capsule and its preparation method

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0021] prescription:

[0022] Entecavir 0.5g

[0023] PEG400 190g

[0024] Propylene glycol 9.5g

[0025] A total of 1000 capsules were made

[0026] Preparation:

[0027] First heat about 80% PEG400 to 40-60°C, add entecavir, stir to dissolve, then add the prescribed amount of propylene glycol, stir evenly, then add the remaining amount of PEG400 to obtain a clear solution; adjust the temperature control system of the dropping pill machine, Heat the dropper of the dropping pill machine and keep it at 50-90°C, cool the temperature of the condensing agent and keep it at -5-40°C; adjust the size of the dropper to control the weight of the soft capsule content, and press it to get it.

Embodiment 2

[0029] prescription:

[0030] Entecavir 1g

[0031] PEG400 190g

[0032] Propylene glycol 7g

[0033] Tween-80 2

[0034] A total of 1000 capsules were made

[0035] Preparation:

[0036] First heat about 80% PEG400 to 40-60°C, add entecavir, stir to dissolve, then add the prescribed amount of propylene glycol and Tween-80, stir well, then add the remaining amount of PEG400 to obtain a clear solution; adjust the dropping pill machine The temperature control system makes the dropper temperature of the dropping pill machine heated and kept at 50-90°C, the temperature of the condensing agent is cooled and kept at -5-40°C, and the size of the dripper is adjusted to control the weight of the soft capsule content, pressing , that is.

Embodiment 3

[0038] prescription:

[0039] Entecavir 1g

[0040] Edible vegetable oil 494.5

[0041] Beeswax 2.5g

[0042] Tween-80 2.0g

[0043] A total of 1000 capsules were made

[0044] Preparation:

[0045] Grind Entecavir into ultra-fine powder, add it to edible vegetable oil, stir to make it evenly suspended, add the prescribed amount of beeswax and Tween-80, and continue to stir to obtain a good oily suspension; adjust the temperature control of the dropping pill machine system, to heat and maintain the dropper temperature of the dropping pill machine at 50-90°C, and cool and maintain the temperature of the condensing agent at -5-40°C; adjust the size of the dripper to control the weight of the contents of the soft capsule, and compress, that is have to.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention relates to an Entecavir soft capsule for treating hepatitis B and process for its preparation, by using Entecavir as raw material, charging auxiliary materials of specific species and proportions, and preparing soft capsule through the conventional techniques in the pharmaceutical industry.

Description

technical field [0001] The invention relates to a novel pharmaceutical preparation, in particular to entecavir soft capsules for treating hepatitis B and a preparation method thereof. Background technique [0002] The morbidity and mortality caused by hepatitis B virus ((HBV) in the world is the most serious among liver viruses. According to the statistics of the World Health Organization, there are about 350 million HBV carriers in the world, causing about 100-200 deaths per year At present, there are two kinds of serum vaccines and DNA recombinant vaccines for prophylaxis; and what is commonly used for therapeutic drugs is alpha-interferon, which is not only expensive and difficult to tolerate, but also has low effective rate (only 25%-40 % of patients had remission). [0003] Entecavir (entecavir) is epoxy hydroxycarbodeoxyguanosine, a deoxyguanosine analogue that can effectively inhibit the replication of hepatitis B virus, and has a strong anti-HBV effect. The chemica...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K9/48A61P1/16A61K31/522A61P31/20
Inventor 严轶东
Owner FUKANGREN BIO PHARMA
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products